Med Life S.A. (BVB:M)
Romania · Delayed Price · Currency is RON 10.60
-0.06 (-0.56%)
At close: Sep 1, 2026
Med Life Ratios and Metrics
Market cap in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| 5,839 | 5,457 | 3,080 | 2,094 | 2,223 | 3,143 | |
Market Cap Growth | 42.86% | 77.16% | 47.10% | -5.80% | -29.29% | 113.39% |
Enterprise Value | 7,772 | 7,234 | 4,689 | 3,501 | 3,228 | 3,759 |
Last Close Price | 11.00 | 10.28 | 5.80 | 3.98 | 4.22 | 5.97 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | - | 484.32 | 123.03 | 568.33 | 69.09 | 30.63 |
Forward PE | 50.00 | 62.30 | 42.18 | 41.90 | 21.46 | 20.19 |
PS Ratio | 1.75 | 1.72 | 1.13 | 0.94 | 1.23 | 2.19 |
PB Ratio | 11.12 | 9.77 | 6.10 | 4.24 | 4.61 | 8.24 |
P/TBV Ratio | - | - | - | - | - | 40.37 |
P/FCF Ratio | 82.77 | 1550.38 | 63.01 | - | 62.60 | 23.14 |
P/OCF Ratio | 22.17 | 24.50 | 10.78 | 11.41 | 12.04 | 13.82 |
PEG Ratio | - | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.33 | 2.28 | 1.73 | 1.58 | 1.78 | 2.62 |
EV/EBITDA Ratio | 16.79 | 20.99 | 15.43 | 17.02 | 17.57 | 15.31 |
EV/EBIT Ratio | 47.60 | 44.84 | 33.24 | 38.25 | 34.26 | 21.23 |
EV/FCF Ratio | 110.18 | 2055.27 | 95.91 | - | 90.91 | 27.67 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 3.85 | 3.46 | 3.34 | 3.16 | 2.47 | 1.91 |
Debt / EBITDA Ratio | 4.37 | 4.32 | 4.27 | 5.45 | 4.82 | 2.50 |
Debt / FCF Ratio | 28.69 | 548.73 | 34.49 | - | 33.49 | 5.35 |
Net Debt / Equity Ratio | 3.55 | 3.14 | 3.12 | 2.96 | 2.28 | 1.55 |
Net Debt / EBITDA Ratio | 5.18 | 5.09 | 5.18 | 7.10 | 5.99 | 2.41 |
Net Debt / FCF Ratio | 26.44 | 498.68 | 32.18 | -82.05 | 30.98 | 4.35 |
Asset Turnover | 1.03 | 1.01 | 0.96 | 0.93 | 1.01 | 1.11 |
Inventory Turnover | 11.14 | 10.83 | 10.79 | 11.14 | 11.30 | 10.60 |
Quick Ratio | 0.55 | 0.55 | 0.46 | 0.54 | 0.55 | 0.67 |
Current Ratio | 0.79 | 0.79 | 0.68 | 0.76 | 0.81 | 0.92 |
Return on Equity (ROE) | -5.46% | -0.72% | 3.35% | -0.85% | 8.67% | 34.73% |
Return on Assets (ROA) | 3.16% | 3.21% | 3.12% | 2.39% | 3.30% | 8.51% |
Return on Invested Capital (ROIC) | 6.86% | -1.48% | 3.00% | -5.01% | 5.57% | 16.09% |
Return on Capital Employed (ROCE) | 6.90% | 6.80% | 6.90% | 4.70% | 6.00% | 17.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Earnings Yield | -0.24% | 0.21% | 0.81% | 0.18% | 1.45% | 3.26% |
FCF Yield | 1.21% | 0.07% | 1.59% | -0.85% | 1.60% | 4.32% |
Buyback Yield / Dilution | - | 0.05% | 0.04% | -0.05% | 0.02% | -0.30% |